(Q52312175)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29685876%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

title

Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29685876%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29685876%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

author name string

Geoffrey M Thiele

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29685876%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Daniel R Anderson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29685876%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

Ted R Mikuls

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29685876%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

language of work or name

English

0 references

publication date

23 April 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29685876%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29685876%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

volume

361

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29685876%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

page(s)

k1036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29685876%20AND%20SRC:MED&resulttype=core&format=json

Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant

24 March 2020

cites work

1 reference

12 December 2020

Elucidation of reaction scheme describing malondialdehyde-acetaldehyde-protein adduct formation

1 reference

12 December 2020

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis

1 reference

12 December 2020

Role of oxidative stress in atherosclerosis

1 reference

12 December 2020

Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failu

1 reference

12 December 2020

Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial.

1 reference

12 December 2020

Burden of major musculoskeletal conditions.

1 reference

12 December 2020

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

1 reference

12 December 2020

Anti-rheumatic drug use and risk of hospitalization for congestive heart failure in rheumatoid arthritis

1 reference

12 December 2020

Inflammation, atherosclerosis, and coronary artery disease

1 reference

12 December 2020

Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation

1 reference

12 December 2020

Endothelial dysfunction in rat adjuvant-induced arthritis: vascular superoxide production by NAD(P)H oxidase and uncoupled endothelial nitric oxide synthase

1 reference

12 December 2020

Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison

1 reference

12 December 2020

HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis

1 reference

12 December 2020

Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study

1 reference

12 December 2020

Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?

1 reference

12 December 2020

Fluvastatin reverses endothelial dysfunction and increased vascular oxidative stress in rat adjuvant-induced arthritis

1 reference

12 December 2020

Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis

1 reference

12 December 2020

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

1 reference

12 December 2020

Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients

1 reference

12 December 2020

Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis

1 reference

12 December 2020

1 reference

12 December 2020

Mortality in rheumatoid arthritis: 2008 update.

1 reference

12 December 2020

Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies

1 reference

12 December 2020

Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte/macrophages

1 reference

12 December 2020

Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies.

1 reference

12 December 2020

Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis

1 reference

12 December 2020

Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study

1 reference

12 December 2020

Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis

1 reference

12 December 2020

Non-invasive assessment of coronary flow reserve and ADMA levels: a case-control study of early rheumatoid arthritis patients.

1 reference

12 December 2020

Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis.

1 reference

12 December 2020

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

1 reference

12 December 2020

Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis

1 reference

12 December 2020

Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?

1 reference

12 December 2020

Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis

1 reference

12 December 2020

Tumor necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study

1 reference

12 December 2020

Clinical improvement in rheumatoid arthritis is associated with healthier microvascular function in patients who respond to antirheumatic therapy

1 reference

12 December 2020

Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging

1 reference

12 December 2020

Involvement of the renin-angiotensin system in the development of vascular damage in a rat model of arthritis: effect of angiotensin receptor blockers

1 reference

12 December 2020

Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis

1 reference

12 December 2020

Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity

1 reference

12 December 2020

Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trial

1 reference

12 December 2020

Increased prevalence of diastolic dysfunction in rheumatoid arthritis.

1 reference

12 December 2020

Are lipid ratios less susceptible to change with systemic inflammation than individual lipid components in patients with rheumatoid arthritis?

1 reference

12 December 2020

Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness

1 reference

12 December 2020

Effect of atorvastatin on inflammation and modification of vascular risk factors in rheumatoid arthritis

1 reference

12 December 2020

Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease

1 reference

12 December 2020

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

1 reference

12 December 2020

Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study

1 reference

12 December 2020

Low frequency of primary lipid screening among medicare patients with rheumatoid arthritis

1 reference

12 December 2020

Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of s

1 reference

12 December 2020

Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study

1 reference

12 December 2020

Hydroxychloroquine use associated with improvement in lipid profiles in rheumatoid arthritis patients

1 reference

12 December 2020

Are the anti-cyclic citrullinated peptide antibodies independent predictors of myocardial involvement in patients with active rheumatoid arthritis?

1 reference

12 December 2020

The influence of rheumatoid arthritis disease characteristics on heart failure.

1 reference

12 December 2020

Tocilizumab monotherapy reduces arterial stiffness as effectively as etanercept or adalimumab monotherapy in rheumatoid arthritis: an open-label randomized controlled trial

1 reference

12 December 2020

Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor α-induced VE-cadherin cleavage.

1 reference

12 December 2020

Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis

1 reference

12 December 2020

Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage.

1 reference

12 December 2020

Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease

1 reference

12 December 2020

Proteomic profiling following immunoaffinity capture of high-density lipoprotein: association of acute-phase proteins and complement factors with proinflammatory high-density lipoprotein in rheumatoid arthritis

1 reference

12 December 2020

Combination of IL-17 and TNFα induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells

1 reference

12 December 2020

Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis

1 reference

12 December 2020

Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.

1 reference

12 December 2020

Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study.

1 reference

12 December 2020

Smoking, smoking cessation, and disease activity in a large cohort of patients with rheumatoid arthritis

1 reference

12 December 2020

Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies.

1 reference

12 December 2020

Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptors

1 reference

12 December 2020

Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study

1 reference

12 December 2020

Dyslipidemia and changes in lipid profiles associated with rheumatoid arthritis and initiation of anti-tumor necrosis factor therapy

1 reference

12 December 2020

Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis

1 reference

12 December 2020

Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease

1 reference

12 December 2020

Carotid atherosclerosis, disease measures, oxidized low-density lipoproteins, and atheroprotective natural antibodies for cardiovascular disease in early rheumatoid arthritis -- an inception cohort study

1 reference

12 December 2020

HDL protein composition alters from proatherogenic into less atherogenic and proinflammatory in rheumatoid arthritis patients responding to rituximab

1 reference

12 December 2020

The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study

1 reference

12 December 2020

Blockade of IL-6 and TNF-α inhibited oxLDL-induced production of MCP-1 via scavenger receptor induction

1 reference

12 December 2020

Etanercept normalises left ventricular mass in patients with rheumatoid arthritis.

1 reference

12 December 2020

Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis

1 reference

12 December 2020

Heart failure risk among patients with rheumatoid arthritis starting a TNF antagonist

1 reference

12 December 2020

Individualised aerobic and resistance exercise training improves cardiorespiratory fitness and reduces cardiovascular risk in patients with rheumatoid arthritis

1 reference

12 December 2020

Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study

1 reference

12 December 2020

Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation

1 reference

12 December 2020

High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis

1 reference

12 December 2020

Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial.

1 reference

12 December 2020

Antibodies to citrullinated peptides and risk of coronary heart disease

1 reference

12 December 2020

Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study

1 reference

12 December 2020

Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis

1 reference

12 December 2020

Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus

1 reference

12 December 2020

Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study

1 reference

12 December 2020

Cholesteryl ester transfer protein in patients with rheumatoid arthritis.

1 reference

12 December 2020

Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis.

1 reference

12 December 2020

Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study

1 reference

12 December 2020

Evaluation of myocardial function in patients with rheumatoid arthritis using strain imaging by speckle-tracking echocardiography

1 reference

12 December 2020

Cardiovascular risk in rheumatoid arthritis: comparing TNF-α blockade with nonbiologic DMARDs

1 reference

12 December 2020

Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease

1 reference

12 December 2020

Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosis

1 reference

12 December 2020

Individualised exercise improves endothelial function in patients with rheumatoid arthritis.

1 reference

12 December 2020

Association of paraoxonase 1 gene polymorphism and enzyme activity with carotid plaque in rheumatoid arthritis.

1 reference

12 December 2020

Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages

1 reference

12 December 2020

Effect of therapeutic inhibition of TNF on circulating endothelial progenitor cells in patients with rheumatoid arthritis.

1 reference

12 December 2020

Adipokines, inflammation, insulin resistance, and carotid atherosclerosis in patients with rheumatoid arthritis

1 reference

12 December 2020

Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis

1 reference

12 December 2020

Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study.

1 reference

12 December 2020

Effect of golimumab on carotid atherosclerotic disease measures and cardiovascular events in inflammatory arthritides

1 reference

12 December 2020

Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study

1 reference

12 December 2020

Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.

1 reference

12 December 2020

Angiogenic T cells are decreased in rheumatoid arthritis patients

1 reference

12 December 2020

The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients

1 reference

12 December 2020

Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis

1 reference

12 December 2020

Selection bias in rheumatic disease research

1 reference

12 December 2020

Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications

1 reference

12 December 2020

The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis

1 reference

12 December 2020

Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis

1 reference

12 December 2020

Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis

1 reference

12 December 2020

Bone erosion is associated with reduction of circulating endothelial progenitor cells and endothelial dysfunction in rheumatoid arthritis.

1 reference

12 December 2020

Left ventricular function in treatment-naive early rheumatoid arthritis

1 reference

12 December 2020

Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease

1 reference

12 December 2020

Disease activity and left ventricular structure in patients with rheumatoid arthritis

1 reference

12 December 2020

An evaluation of risk factors for major adverse cardiovascular events during tocilizumab therapy

1 reference

12 December 2020

Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis

1 reference

12 December 2020

The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores

1 reference

12 December 2020

Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis

1 reference

12 December 2020

Insulin resistance in rheumatoid arthritis: disease-related indicators and associations with the presence and progression of subclinical atherosclerosis.

1 reference

12 December 2020

The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.

1 reference

12 December 2020

Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation

1 reference

12 December 2020

Newly Identified Antiatherosclerotic Activity of Methotrexate and Adalimumab: Complementary Effects on Lipoprotein Function and Macrophage Cholesterol Metabolism

1 reference

12 December 2020

Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration

1 reference

12 December 2020

The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease

1 reference

12 December 2020

The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis

1 reference

12 December 2020

Disease activity in rheumatoid arthritis and the risk of cardiovascular events

1 reference

12 December 2020

Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study.

1 reference

12 December 2020

Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients.

1 reference

12 December 2020

Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis

1 reference

12 December 2020

Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative

1 reference

12 December 2020

Derivation and internal validation of an expanded cardiovascular risk prediction score for rheumatoid arthritis: a Consortium of Rheumatology Researchers of North America Registry Study

1 reference

12 December 2020

Protein carbamylation and cardiovascular disease

1 reference

12 December 2020

Cause-Specific Mortality in Male US Veterans With Rheumatoid Arthritis

1 reference

12 December 2020

Risk factors for the rapid increase in risk of acute coronary events in patients with new-onset rheumatoid arthritis: a nested case-control study

1 reference

12 December 2020

Brief report: lack of replication of an association between anti-citrullinated fibrinogen and subclinical atherosclerosis in patients with rheumatoid arthritis

1 reference

12 December 2020

Association of Light-Intensity Physical Activity With Lower Cardiovascular Disease Risk Burden in Rheumatoid Arthritis

1 reference

12 December 2020

Association of Elevations of Specific T Cell and Monocyte Subpopulations in Rheumatoid Arthritis With Subclinical Coronary Artery Atherosclerosis

1 reference

12 December 2020

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology

1 reference

12 December 2020

Association of Triple Therapy With Improvement in Cholesterol Profiles Over Two-Year Followup in the Treatment of Early Aggressive Rheumatoid Arthritis Trial

1 reference

12 December 2020

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis

1 reference

12 December 2020

Hydroxychloroquine Use Is Associated With Decreased Incident Cardiovascular Events in Rheumatoid Arthritis Patients

1 reference

12 December 2020

Brief Report: Proatherogenic Cytokine Microenvironment in the Aortic Adventitia of Patients With Rheumatoid Arthritis

1 reference

12 December 2020

Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation

1 reference

12 December 2020

Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis

1 reference

12 December 2020

Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti-High-Density Lipoprotein Antibodies in Patients With Rheumatoid Arthritis: Potential Implications for Cardiovascular Disease

1 reference

12 December 2020

Accelerated transformation of macrophage-derived foam cells in the presence of collagen-induced arthritis mice serum is associated with dyslipidemia

1 reference

12 December 2020

Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis

1 reference

12 December 2020

Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist

1 reference

12 December 2020

Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study

1 reference

12 December 2020

Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial.

1 reference

12 December 2020

Association of Rheumatoid Factors With Subclinical and Clinical Atherosclerosis in African American Women: The Multiethnic Study of Atherosclerosis.

1 reference

12 December 2020

Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis

1 reference

12 December 2020

Oxidative Stress Relevance in the Pathogenesis of the Rheumatoid Arthritis: A Systematic Review

1 reference

12 December 2020

Increased inflammation and disease activity among current cigarette smokers with rheumatoid arthritis: a cross-sectional analysis of US veterans.

1 reference

12 December 2020

Gaps in Addressing Cardiovascular Risk in Rheumatoid Arthritis: Assessing Performance Using Cardiovascular Quality Indicators

1 reference

12 December 2020

Improvement of High-Density Lipoprotein Function in Patients With Early Rheumatoid Arthritis Treated With Methotrexate Monotherapy or Combination Therapies in a Randomized Controlled Trial

1 reference

12 December 2020

Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis

1 reference

12 December 2020

Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study

1 reference

12 December 2020

Association of Anti-Citrullinated Peptide Antibodies With Coronary Artery Calcification in Rheumatoid Arthritis

1 reference

12 December 2020

EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update

1 reference

12 December 2020

Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process

1 reference

12 December 2020

Anti-inflammatory treatment improves high-density lipoprotein function in rheumatoid arthritis

1 reference

12 December 2020

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis

1 reference

12 December 2020

Association of anti-citrullinated protein or peptide antibodies with left ventricular structure and function in rheumatoid arthritis.

1 reference

12 December 2020

Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation.

1 reference

12 December 2020

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis.

1 reference

12 December 2020

Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study

1 reference

12 December 2020

Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis

1 reference

12 December 2020

Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.

1 reference

12 December 2020

Impact of Obesity and Adiposity on Inflammatory Markers in Patients With Rheumatoid Arthritis.

1 reference

12 December 2020

Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis.

1 reference

12 December 2020

Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients.

1 reference

12 December 2020

Direct antioxidant properties of methotrexate: Inhibition of malondialdehyde-acetaldehyde-protein adduct formation and superoxide scavenging

1 reference

12 December 2020

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.K1036

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29685876%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29685876%20AND%20SRC:MED&resulttype=core&format=json

24 March 2020

1 reference